BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11286009)

  • 1. The contribution of mesangial cell proliferation to progressive glomerular injury.
    Doi T
    J Med Invest; 2001 Feb; 48(1-2):1-4. PubMed ID: 11286009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory mechanism in glomerular mesangial cell proliferation.
    Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
    J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas6, warfarin, and kidney diseases.
    Yanagita M
    Clin Exp Nephrol; 2004 Dec; 8(4):304-9. PubMed ID: 15619028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation.
    Yanagita M; Ishii K; Ozaki H; Arai H; Nakano T; Ohashi K; Mizuno K; Kita T; Doi T
    J Am Soc Nephrol; 1999 Dec; 10(12):2503-9. PubMed ID: 10589688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of glomerular mesangial cells to progressive glomerulosclerosis.
    Striker LJ; Doi T; Elliot S; Striker GE
    Semin Nephrol; 1989 Dec; 9(4):318-28. PubMed ID: 2688008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression.
    Jiang Y; Cheng DW; Levi E; Singh LP
    J Cell Biochem; 2006 May; 98(1):208-20. PubMed ID: 16408277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclins in cAMP inhibition of glomerular mesangial cell proliferation.
    Ito C; Yamamoto H; Furukawa Y; Takeda S; Akimoto T; Iimura O; Ando Y; Asano Y; Kusano E
    Clin Sci (Lond); 2004 Jul; 107(1):81-7. PubMed ID: 14992682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
    J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.
    Kwak DH; Lee S; Kim SJ; Ahn SH; Song JH; Choo YK; Choi BK; Jung KY
    Life Sci; 2005 Sep; 77(20):2540-51. PubMed ID: 15939439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
    Ahn JD; Morishita R; Kaneda Y; Kim HJ; Kim YD; Lee HJ; Lee KU; Park JY; Kim YH; Park KK; Chang YC; Yoon KH; Kwon HS; Park KG; Lee IK
    Gene Ther; 2004 Jun; 11(11):916-23. PubMed ID: 14961072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3.
    Yanagita M; Arai H; Nakano T; Ohashi K; Mizuno K; Fukatsu A; Doi T; Kita T
    J Biol Chem; 2001 Nov; 276(45):42364-9. PubMed ID: 11546821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of thrombin on cell proliferation and plasminogen activator inhibitor type (PAI-1) expression in human embryonic glomerular mesangial cells].
    He QN; Yi ZW; Chen XM; Fu B
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):191-3. PubMed ID: 12212221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells.
    Xu M; Wang YP; Luo WB; Xuan LJ
    Acta Pharmacol Sin; 2001 Jul; 22(7):629-33. PubMed ID: 11749828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial cell-predominant functional gene, megsin.
    Inagi R; Nangaku M; Miyata T; Kurokawa K
    Clin Exp Nephrol; 2003 Jun; 7(2):87-92. PubMed ID: 14586725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
    Eremina V; Cui S; Gerber H; Ferrara N; Haigh J; Nagy A; Ema M; Rossant J; Jothy S; Miner JH; Quaggin SE
    J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.
    Rho YI; Kwak DH; Lee S; Ahn SH; Baek SH; Song JH; Choo YK; Choi BK; Jung KY
    Life Sci; 2004 May; 75(1):51-62. PubMed ID: 15102521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mesangial cells in glomerular pathology.
    Hawkins NJ; Wakefield D; Charlesworth JA
    Pathology; 1990 Jan; 22(1):24-32. PubMed ID: 2194156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mesangial cell proliferation.
    Schöcklmann HO; Lang S; Sterzel RB
    Kidney Int; 1999 Oct; 56(4):1199-207. PubMed ID: 10610410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of diabetic mesangial cell hypertrophy: a proliferation of novel factors.
    Wolf G
    J Am Soc Nephrol; 2002 Oct; 13(10):2611-2613. PubMed ID: 12239252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.